ResearcherInstitut Gustave RoussyActive in the last 2 years

Siriane Anglaret

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5107101355. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2024: 1 paper

Papers 1

[NALIRIFOX in first-line therapy for metastatic pancreatic adenocarcinoma]. Co-author DOI 10.1016/j.bulcan.2024.06.007 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marc Hilmi · 1 shared paper, 2024 · strength 0.46
- Paper [NALIRIFOX in first-line therapy for metastatic pancreatic adenocarcinoma]. DOI 10.1016/j.bulcan.2024.06.007 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.